101 results
424B5
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Prospectus supplement for primary offering
4:52pm
mechanisms including cell death occurring through mitochondrial pore permeability (cyclophilin D). Inhibition of cyclophilin D, therefore, may play … an important role in protection from cell death. Cyclophilin A binding to CD147 is known to play a role in inflammation, cyclophilin B plays a role
8-K
EX-99.1
HEPA
Hepion Pharmaceuticals Inc
24 Jul 23
Regulation FD Disclosure
4:04pm
common cancer - related death*905,000 new cases and830,000 deaths globally*30,000 new cases annually in U.S.* with 5 - year survival of 18 … fibrosis is well established Consequences of NASH may be severe (need for liver transplant, cancer, cardiovascular disease, and death)
8 NASH DISEASE
424B5
HEPA
Hepion Pharmaceuticals Inc
21 Jul 23
Prospectus supplement for primary offering
4:39pm
fibrosis.
Cyclophilins are pleiotropic enzymes that play a role in injury and steatosis through mechanisms including cell death occurring through … injury and death. Cyclophilin A binding to CD147 is known to play a role in inflammation, cyclophilin B plays a role in fibrosis through collagen
8-K
EX-99.1
4wyg7t7te
22 May 23
Regulation FD Disclosure
1:05pm
8-K
EX-99.1
pbu5v44jl8s 1lpqt
17 Oct 22
Regulation FD Disclosure
5:13pm
DEFA14A
9z3hkiuwbw7v
14 Jun 22
Additional proxy soliciting materials
4:05pm
8-K
EX-99.1
wmmimnuv
27 May 22
Regulation FD Disclosure
8:44am
8-K
6ttqb 4hj6v
12 Jan 22
Hepion Pharmaceuticals Announces Death of Director, Thomas Adams
10:08am
8-K
EX-99.1
qi18nhzrdk5 wvz
12 Jan 22
Hepion Pharmaceuticals Announces Death of Director, Thomas Adams
10:08am
8-K
EX-99.1
1iia3qb6cb61plnkelui
10 Jan 22
Regulation FD Disclosure
6:02am
8-K
EX-99
udq9t3nt3r
21 Dec 21
Hepion Pharmaceuticals Announces FDA Clearance of IND Application for CRV431 in the Treatment of Liver Cancer
8:25am
8-K
EX-99.1
3uk0dx rmt8dimutktk
16 Nov 21
Hepion Pharmaceuticals and FibroFind Announce Anti-Cancer Activity of CRV431 in a Nonclinical Liver Cancer Study
8:53am